Report Detail

Other Global NGS-based RNA-sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4606072
  • |
  • 02 August, 2024
  • |
  • Global
  • |
  • 128 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global NGS-based RNA-sequencing market size was valued at USD 2605.8 million in 2023 and is forecast to a readjusted size of USD 7668 million by 2030 with a CAGR of 16.7% during review period.
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
The Global Info Research report includes an overview of the development of the NGS-based RNA-sequencing industry chain, the market status of Research & Academia (Sequencing by Synthesis, Ion Semiconductor Sequencing), Hospitals & Clinics (Sequencing by Synthesis, Ion Semiconductor Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of NGS-based RNA-sequencing.
Regionally, the report analyzes the NGS-based RNA-sequencing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global NGS-based RNA-sequencing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the NGS-based RNA-sequencing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the NGS-based RNA-sequencing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sequencing by Synthesis, Ion Semiconductor Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the NGS-based RNA-sequencing market.
Regional Analysis: The report involves examining the NGS-based RNA-sequencing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the NGS-based RNA-sequencing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to NGS-based RNA-sequencing:
Company Analysis: Report covers individual NGS-based RNA-sequencing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards NGS-based RNA-sequencing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research & Academia, Hospitals & Clinics).
Technology Analysis: Report covers specific technologies relevant to NGS-based RNA-sequencing. It assesses the current state, advancements, and potential future developments in NGS-based RNA-sequencing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the NGS-based RNA-sequencing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
NGS-based RNA-sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Market segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
Market segment by players, this report covers
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe NGS-based RNA-sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of NGS-based RNA-sequencing, with revenue, gross margin and global market share of NGS-based RNA-sequencing from 2019 to 2024.
Chapter 3, the NGS-based RNA-sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and NGS-based RNA-sequencing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of NGS-based RNA-sequencing.
Chapter 13, to describe NGS-based RNA-sequencing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of NGS-based RNA-sequencing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of NGS-based RNA-sequencing by Type
    • 1.3.1 Overview: Global NGS-based RNA-sequencing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global NGS-based RNA-sequencing Consumption Value Market Share by Type in 2023
    • 1.3.3 Sequencing by Synthesis
    • 1.3.4 Ion Semiconductor Sequencing
    • 1.3.5 Single-molecule Real-time Sequencing
    • 1.3.6 Nanopore Sequencing
  • 1.4 Global NGS-based RNA-sequencing Market by Application
    • 1.4.1 Overview: Global NGS-based RNA-sequencing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Research & Academia
    • 1.4.3 Hospitals & Clinics
    • 1.4.4 Pharmaceutical & Biotechnology Companies
    • 1.4.5 Others
  • 1.5 Global NGS-based RNA-sequencing Market Size & Forecast
  • 1.6 Global NGS-based RNA-sequencing Market Size and Forecast by Region
    • 1.6.1 Global NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global NGS-based RNA-sequencing Market Size by Region, (2019-2030)
    • 1.6.3 North America NGS-based RNA-sequencing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe NGS-based RNA-sequencing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific NGS-based RNA-sequencing Market Size and Prospect (2019-2030)
    • 1.6.6 South America NGS-based RNA-sequencing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa NGS-based RNA-sequencing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Illumina
    • 2.1.1 Illumina Details
    • 2.1.2 Illumina Major Business
    • 2.1.3 Illumina NGS-based RNA-sequencing Product and Solutions
    • 2.1.4 Illumina NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Illumina Recent Developments and Future Plans
  • 2.2 Thermo Fischer Scientific
    • 2.2.1 Thermo Fischer Scientific Details
    • 2.2.2 Thermo Fischer Scientific Major Business
    • 2.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Product and Solutions
    • 2.2.4 Thermo Fischer Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Thermo Fischer Scientific Recent Developments and Future Plans
  • 2.3 Oxford Nanopore
    • 2.3.1 Oxford Nanopore Details
    • 2.3.2 Oxford Nanopore Major Business
    • 2.3.3 Oxford Nanopore NGS-based RNA-sequencing Product and Solutions
    • 2.3.4 Oxford Nanopore NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Oxford Nanopore Recent Developments and Future Plans
  • 2.4 Agilent Technologies
    • 2.4.1 Agilent Technologies Details
    • 2.4.2 Agilent Technologies Major Business
    • 2.4.3 Agilent Technologies NGS-based RNA-sequencing Product and Solutions
    • 2.4.4 Agilent Technologies NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Agilent Technologies Recent Developments and Future Plans
  • 2.5 BGI
    • 2.5.1 BGI Details
    • 2.5.2 BGI Major Business
    • 2.5.3 BGI NGS-based RNA-sequencing Product and Solutions
    • 2.5.4 BGI NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 BGI Recent Developments and Future Plans
  • 2.6 PerkinElmer
    • 2.6.1 PerkinElmer Details
    • 2.6.2 PerkinElmer Major Business
    • 2.6.3 PerkinElmer NGS-based RNA-sequencing Product and Solutions
    • 2.6.4 PerkinElmer NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 PerkinElmer Recent Developments and Future Plans
  • 2.7 QIAGEN
    • 2.7.1 QIAGEN Details
    • 2.7.2 QIAGEN Major Business
    • 2.7.3 QIAGEN NGS-based RNA-sequencing Product and Solutions
    • 2.7.4 QIAGEN NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 QIAGEN Recent Developments and Future Plans
  • 2.8 Eurofins Scientific
    • 2.8.1 Eurofins Scientific Details
    • 2.8.2 Eurofins Scientific Major Business
    • 2.8.3 Eurofins Scientific NGS-based RNA-sequencing Product and Solutions
    • 2.8.4 Eurofins Scientific NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.9 Roche
    • 2.9.1 Roche Details
    • 2.9.2 Roche Major Business
    • 2.9.3 Roche NGS-based RNA-sequencing Product and Solutions
    • 2.9.4 Roche NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Roche Recent Developments and Future Plans
  • 2.10 Takara Bio
    • 2.10.1 Takara Bio Details
    • 2.10.2 Takara Bio Major Business
    • 2.10.3 Takara Bio NGS-based RNA-sequencing Product and Solutions
    • 2.10.4 Takara Bio NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Takara Bio Recent Developments and Future Plans
  • 2.11 GENEWIZ
    • 2.11.1 GENEWIZ Details
    • 2.11.2 GENEWIZ Major Business
    • 2.11.3 GENEWIZ NGS-based RNA-sequencing Product and Solutions
    • 2.11.4 GENEWIZ NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 GENEWIZ Recent Developments and Future Plans
  • 2.12 Hamilton
    • 2.12.1 Hamilton Details
    • 2.12.2 Hamilton Major Business
    • 2.12.3 Hamilton NGS-based RNA-sequencing Product and Solutions
    • 2.12.4 Hamilton NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Hamilton Recent Developments and Future Plans
  • 2.13 Macrogen
    • 2.13.1 Macrogen Details
    • 2.13.2 Macrogen Major Business
    • 2.13.3 Macrogen NGS-based RNA-sequencing Product and Solutions
    • 2.13.4 Macrogen NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Macrogen Recent Developments and Future Plans
  • 2.14 Zymo Research
    • 2.14.1 Zymo Research Details
    • 2.14.2 Zymo Research Major Business
    • 2.14.3 Zymo Research NGS-based RNA-sequencing Product and Solutions
    • 2.14.4 Zymo Research NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Zymo Research Recent Developments and Future Plans
  • 2.15 Tecan Genomics
    • 2.15.1 Tecan Genomics Details
    • 2.15.2 Tecan Genomics Major Business
    • 2.15.3 Tecan Genomics NGS-based RNA-sequencing Product and Solutions
    • 2.15.4 Tecan Genomics NGS-based RNA-sequencing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Tecan Genomics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global NGS-based RNA-sequencing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of NGS-based RNA-sequencing by Company Revenue
    • 3.2.2 Top 3 NGS-based RNA-sequencing Players Market Share in 2023
    • 3.2.3 Top 6 NGS-based RNA-sequencing Players Market Share in 2023
  • 3.3 NGS-based RNA-sequencing Market: Overall Company Footprint Analysis
    • 3.3.1 NGS-based RNA-sequencing Market: Region Footprint
    • 3.3.2 NGS-based RNA-sequencing Market: Company Product Type Footprint
    • 3.3.3 NGS-based RNA-sequencing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global NGS-based RNA-sequencing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global NGS-based RNA-sequencing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global NGS-based RNA-sequencing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global NGS-based RNA-sequencing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America NGS-based RNA-sequencing Consumption Value by Type (2019-2030)
  • 6.2 North America NGS-based RNA-sequencing Consumption Value by Application (2019-2030)
  • 6.3 North America NGS-based RNA-sequencing Market Size by Country
    • 6.3.1 North America NGS-based RNA-sequencing Consumption Value by Country (2019-2030)
    • 6.3.2 United States NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico NGS-based RNA-sequencing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe NGS-based RNA-sequencing Consumption Value by Type (2019-2030)
  • 7.2 Europe NGS-based RNA-sequencing Consumption Value by Application (2019-2030)
  • 7.3 Europe NGS-based RNA-sequencing Market Size by Country
    • 7.3.1 Europe NGS-based RNA-sequencing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 7.3.3 France NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy NGS-based RNA-sequencing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific NGS-based RNA-sequencing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific NGS-based RNA-sequencing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region
    • 8.3.1 Asia-Pacific NGS-based RNA-sequencing Consumption Value by Region (2019-2030)
    • 8.3.2 China NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 8.3.5 India NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia NGS-based RNA-sequencing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America NGS-based RNA-sequencing Consumption Value by Type (2019-2030)
  • 9.2 South America NGS-based RNA-sequencing Consumption Value by Application (2019-2030)
  • 9.3 South America NGS-based RNA-sequencing Market Size by Country
    • 9.3.1 South America NGS-based RNA-sequencing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina NGS-based RNA-sequencing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa NGS-based RNA-sequencing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa NGS-based RNA-sequencing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country
    • 10.3.1 Middle East & Africa NGS-based RNA-sequencing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia NGS-based RNA-sequencing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE NGS-based RNA-sequencing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 NGS-based RNA-sequencing Market Drivers
  • 11.2 NGS-based RNA-sequencing Market Restraints
  • 11.3 NGS-based RNA-sequencing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 NGS-based RNA-sequencing Industry Chain
  • 12.2 NGS-based RNA-sequencing Upstream Analysis
  • 12.3 NGS-based RNA-sequencing Midstream Analysis
  • 12.4 NGS-based RNA-sequencing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on NGS-based RNA-sequencing. Industry analysis & Market Report on NGS-based RNA-sequencing is a syndicated market report, published as Global NGS-based RNA-sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of NGS-based RNA-sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,686.56
    4,029.84
    5,373.12
    3,198.12
    4,797.18
    6,396.24
    529,203.60
    793,805.40
    1,058,407.20
    292,876.80
    439,315.20
    585,753.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report